Medical News

RSS

Arcadia Biosciences' SONOVA 400 receives FDA approval as a dietary supplement ingredient

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the U.S. Food and Drug Administration (FDA) regulatory process for SONOVA™ 400.

8 Dec 2009

Anesiva receives notification letter from NASDAQ Stock Market

Anesiva, Inc. announced today that on December 2, 2009, Anesiva received a letter from The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $5,000,000 during the last 30 consecutive business days and that therefore

8 Dec 2009

Consumer Watchdog: Opponents of health reform are fear-mongering relentlessly during Senate debate

Opponents of health reform are fear-mongering relentlessly during prolonged Senate debate, said Consumer Watchdog, spinning endlessly the lobbying messages of the insurance industry.

8 Dec 2009

HALO procedure can help manage Barrett's esophagus and prevent esophageal cancer

Cancer prevention is an important goal for all Houstonians and Bay Area Gastroenterology advises that early detection can prevent esophageal cancer.

8 Dec 2009

Seattle-based Qualis Health selects Genuine Interactive as its interactive agency of record

Qualis Health names Genuine Interactive as its interactive agency of record, according to John Grayson, president of the interactive marketing agency (http://www.genuineinteractive.com). The Seattle-based Qualis Health chose Genuine Interactive after a national review of firms.

8 Dec 2009

BARDA cancels PharmAthene's RFP for Recombinant Protective Antigen Anthrax Vaccine

PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services Biomedical Research and Development Authority (BARDA) has canceled its request for proposal (RFP) for Recombinant Protective Antigen Anthrax Vaccine for the Strategic National Stockpile (RFP BARDA 08-15).

8 Dec 2009

New data provide comprehensive review of emerging role of small airways in asthma management

Teva Respiratory, a division of Teva Pharmaceutical Industries Ltd., today announced the publication of four articles in a special supplement of the December issue of the Journal of Allergy and Clinical Immunology (JACI), providing a comprehensive scientific review of the emerging role of the small airways in the understanding and treatment of asthma.

8 Dec 2009

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Cell Therapeutics, Inc. announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals.

8 Dec 2009

$Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma$

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

8 Dec 2009

Documentary presents inspirational story of kids with autism and Asperger's syndrome

Millions of people around the world are achieving success every day, but no accomplishments are as impressive as those achieved by people for whom everyday life is a challenge. "Kids With Cameras," a documentary presented by Polaris Media Group, to be released on December 15th, is a heartwarming and inspirational story of many such accomplishments achieved by kids with autism and Asperger's syndrome.

8 Dec 2009

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology’s annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

8 Dec 2009

Tips for avoiding holiday weight gain

With obesity rates at all time highs, and the season of food, comfort and overindulgence right around the corner, the fear of weight gain is very real for most people. Keep off those pesky holiday pounds by upping fitness this December, and get a jump start on that New Year's resolution with the help of some guidance from Life123.com, a leading source of expert advice.

8 Dec 2009

AbSorber receives patent protection for its XM-ONE in the European countries

AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product.

8 Dec 2009

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Sickle cell disease, a condition characterized by deformed and dysfunctional red blood cells, is one of the most common genetic blood disorders affecting millions of people around the world, including more than 70,000 Americans (National Heart, Lung, and Blood Institute.

8 Dec 2009

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Wounds suffered by patients with diabetes tend to heal poorly. For treatment to work, the patient's physician must discuss the situation with specialists and nursing staff to decide on the best approach. However, e-mailing the files containing the diagnosis and discussing them on the telephone is a time-consuming process.

8 Dec 2009

Department of Health reminds at-risk Pennsylvanians to receive H1N1 vaccination

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 2,940,300 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

8 Dec 2009

Erbitux gaining market share of Avastin in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite its dominance in early lines of metastatic colorectal cancer treatment, Roche/Chugai's Avastin will face increasing competition from Bristol-Myers Squibb/Eli Lilly/Merck KGaA's Erbitux in Germany, France and Spain.

8 Dec 2009

TAFP and RemitDATA team up to improve revenue and reimbursement trends

RemitDATA, Inc., a leading provider of web-based productivity tools and benchmarking to the outpatient healthcare market, today announced that Texas Academy of Family Physicians (TAFP), the largest medical specialty organization, serving over 5,500 family physicians in Texas, has joined forces with RemitDATA to aggregate members' reimbursement data and provide real-time payer benchmarking to help TAFP identify problematic payers and troubling reimbursement trends before they turn into cash-flow pitfalls.

8 Dec 2009

Muscle Flex returns to 'Current Information' status with PinkSheets.com

Muscle Flex Inc. (www.MuscleFlex.com) announced today that it has returned to 'Current Information' status with PinkSheets.com after filing its required financial information.

8 Dec 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Tranzyme Pharma today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.

8 Dec 2009

Medical News

Arcadia Biosciences' SONOVA 400 receives FDA approval as a dietary supplement ingredient

Anesiva receives notification letter from NASDAQ Stock Market

Consumer Watchdog: Opponents of health reform are fear-mongering relentlessly during Senate debate

HALO procedure can help manage Barrett's esophagus and prevent esophageal cancer

Seattle-based Qualis Health selects Genuine Interactive as its interactive agency of record

BARDA cancels PharmAthene's RFP for Recombinant Protective Antigen Anthrax Vaccine

New data provide comprehensive review of emerging role of small airways in asthma management

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Documentary presents inspirational story of kids with autism and Asperger's syndrome

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Tips for avoiding holiday weight gain

AbSorber receives patent protection for its XM-ONE in the European countries

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Department of Health reminds at-risk Pennsylvanians to receive H1N1 vaccination

Erbitux gaining market share of Avastin in Europe

TAFP and RemitDATA team up to improve revenue and reimbursement trends

Muscle Flex returns to 'Current Information' status with PinkSheets.com

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News